A study presented Sunday, November 6 at the 62nd Annual Meeting for the American Association for the Study of Liver Diseases (AASLD) may have moved us a big step closer to a hepatitis C virus (HCV) treatment future that does away with interferon. That study found…Read More
Category Archives: Hepatitis C care & treatment
November 6, 2011
Merck and Inhibitex Drugs Have Potent Anti-HCV Activity
Two posters exhibited Saturday, November 6, at the 62nd Annual Meeting for the american Association for the Study of Liver Diseases (AASLD) in San Francisco, reported that two new direct-acting antiviral (DAA) drugs against hepatitis C virus (HCV) showed very potent activity against the virus. The…Read More
May 9, 2001 From a study reported in the April 24, 2011 issue of AIDS, people co-infected with HIV and hepatitis C who stop taking their HIV meds run about a 2.5 times higher risk of liver fibrosis compared to those who don’t interrupt their HIV…Read More
Study results announced in the journal AIDS show that people co-infected with HIV and hepatitis C could have better and earlier responses if they used peg-interferon twice a week for the first four weeks of treatment rather than the standard once-a-week injection. Co-infected people generally experience…Read More
From a study reported in the April 24, 2011 issue of AIDS, people co-infected with HIV and hepatitis C who stop taking their HIV meds run about a 2.5 times higher risk of liver fibrosis compared to those who don’t interrupt their HIV regimens. This finding…Read More
April 17, 2011 Promising early results from the EMERGE study of the new drug peg-interferon lambda show that people tolerate it better than the current peg-interferon alpha. The lambda version also appears to suppress hepatitis C (HCV) to undetectable levels in more people than the alpha…Read More
April 12, 2011 News from the recent European liver conference EASL reported on a two-drug regimen that may cure hepatitis C (HCV) without having to use either of the drugs found in standard treatment. Although this new regimen of experimental drugs may cure only some people…Read More